Oramed Pharmaceuticals (ORMP) Asset Utilization Ratio (2016 - 2025)

Oramed Pharmaceuticals has reported Asset Utilization Ratio for 8 years, with the latest figure at 0.01 in Q4 2025.

• For the quarter ending Q4 2025, Asset Utilization Ratio changed N/A year-over-year to 0.01; the trailing twelve-month figure through Dec 2025 stood at 0.01 (changed N/A YoY), and the FY2025 full-year result was 0.01, changed N/A from the prior year.
• Asset Utilization Ratio for Q4 2025 stood at 0.01, down from 0.01 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.05 in Q3 2021, with the low at 0.01 in Q4 2023.
• Historically, Asset Utilization Ratio has averaged 0.02 across 4 years, with a median of 0.02 in 2022.
• The largest YoY upside for Asset Utilization Ratio was 31.65% in 2023 against a maximum downside of 66.92% in 2023.
• Oramed Pharmaceuticals' Asset Utilization Ratio stood at 0.05 in 2021, then sank by 60.53% to 0.02 in 2022, then slumped by 66.92% to 0.01 in 2023, then surged by 49.28% to 0.01 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.01 (Q4 2025), 0.01 (Q3 2025), and 0.01 (Q2 2025), per Business Quant data.